---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-25-000142"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2025-10-06T23:59:59+00:00"
generated_at: "2026-05-17T04:35:15.628457+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Salarius raises $6.2M; believes Nasdaq equity compliance regained ahead of Oct 20 deadline

## Summary
- Raised $2.4M from ATM sales (434,882 shares) and $3.8M from C/M Capital Master Fund purchase agreement.
- Believes stockholders' equity now exceeds $2.5M as of Oct 6, 2025; awaiting Nasdaq confirmation.
- Previously faced Nasdaq delisting risk if compliance not met by Oct 20, 2025.
- Q3 10-Q expected to reflect equity above $2.5M as of Sept 30, 2025.

## SEC filing metadata
- accession: 0001615219-25-000142
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2025-10-06T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000142/0001615219-25-000142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000142/flks-20251006.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-25-000142
- JSON: https://secwatch.observer/filing/0001615219-25-000142.json
- Plain text: https://secwatch.observer/filing/0001615219-25-000142.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.